Sign Up to like & get
recommendations!
1
Published in 2019 at "Immunology"
DOI: 10.1158/1538-7445.am2019-3183
Abstract: Background: Genetically engineered affinity-enhanced autologous SPEAR T-cells (AFPc332T-cells) directed towards the HLA-A*02-restricted AFP peptide FMNKFIYEI are being tested in an ongoing Phase 1 trial to evaluate safety and antitumor activity in patients with hepatocellular carcinoma…
read more here.
Keywords:
hepatocellular carcinoma;
afp spear;
spear cells;
week ... See more keywords